acetylcysteine and Diffuse Parenchymal Lung Disease

acetylcysteine has been researched along with Diffuse Parenchymal Lung Disease in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Khodamoradi, Z; Mehrabi, S; Moradi, MM; Nazarinia, MA	1
Bast, A; den Hartog, GJ; Haenen, GR; Weseler, AR	1
Behr, J; Costabel, U	1
Demedts, MG; Thomeer, M; Wuyts, WA	1
Gillissen, A	1
Lota, HK; Wells, AU	1
Dominique, S; Marie, I	1
Nukiwa, T	1
Azuma, A	1
Cottin, V	1

Reviews

6 review(s) available for acetylcysteine and Diffuse Parenchymal Lung Disease

Article	Year
Oxidative stress and antioxidants in interstitial lung disease. Current opinion in pulmonary medicine, 2010, Volume: 16, Issue:5 Topics: Acetylcysteine; Antioxidants; Humans; Lung Diseases, Interstitial; Oxidative Stress; Pyridones; Reactive Oxygen Species	2010
Newer modes of treating interstitial lung disease. Current opinion in pulmonary medicine, 2011, Volume: 17, Issue:5 Topics: Acetylcysteine; Adrenal Cortex Hormones; Azathioprine; Humans; Lung Diseases, Interstitial; Lung Transplantation; Palliative Care; Pyridones	2011
The evolving pharmacotherapy of pulmonary fibrosis. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:1 Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Humans; Idiopathic Interstitial Pneumonias; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Treatment Outcome	2013
[Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:4 Pt 2 Topics: Acetylcysteine; Adult; Biomarkers; Biopsy; Bronchoalveolar Lavage; Cyclophosphamide; Dermatomyositis; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Lung Transplantation; Middle Aged; Multicenter Studies as Topic; Polymyositis; Prevalence; Prognosis; Radiography, Thoracic; Randomized Controlled Trials as Topic; Respiratory Function Tests; Tomography, X-Ray Computed	2006
[Newly developed therapeutic drugs for idiopathic interstitial pneumonias]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jun-10, Volume: 95, Issue:6 Topics: Acetylcysteine; Drug Design; Drug Therapy, Combination; Humans; Interferon-gamma; Lung Diseases, Interstitial; Prednisolone; Pyridones; Randomized Controlled Trials as Topic	2006
[Idiopathic interstitial pneumonia: treatment]. Revue des maladies respiratoires, 2006, Volume: 23, Issue:4 Pt 2 Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors	2006

Trials

1 trial(s) available for acetylcysteine and Diffuse Parenchymal Lung Disease

Article	Year
Effects of N-acetylcysteine on Pulmonary Functions in Patients with Systemic Sclerosis: A Randomized Double Blind, Placebo Controlled Study. Current rheumatology reviews, 2020, Volume: 16, Issue:2 Topics: Acetylcysteine; Adult; Double-Blind Method; Female; Free Radical Scavengers; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Respiratory Function Tests; Scleroderma, Systemic; Treatment Outcome; Young Adult	2020

Article

Year

Effects of N-acetylcysteine on Pulmonary Functions in Patients with Systemic Sclerosis: A Randomized Double Blind, Placebo Controlled Study.

Current rheumatology reviews, 2020, Volume: 16, Issue:2

Topics: Acetylcysteine; Adult; Double-Blind Method; Female; Free Radical Scavengers; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Respiratory Function Tests; Scleroderma, Systemic; Treatment Outcome; Young Adult

2020

Other Studies

3 other study(ies) available for acetylcysteine and Diffuse Parenchymal Lung Disease

Article	Year
[Interstitial lung diseases - historical development, current status, future prospects]. Pneumologie (Stuttgart, Germany), 2010, Volume: 64, Issue:9 Topics: Acetylcysteine; Antioxidants; History, 19th Century; Humans; Lung Diseases, Interstitial; Pulmonary Fibrosis; Sarcoidosis	2010
[Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness]. Pneumologie (Stuttgart, Germany), 2011, Volume: 65, Issue:9 Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Arthritis; Bronchitis; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Expectorants; Free Radical Scavengers; Humans; Lung Diseases; Lung Diseases, Interstitial; Pulmonary Disease, Chronic Obstructive	2011
[Diffuse lung diseases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jun-10, Volume: 95, Issue:6 Topics: Acetylcysteine; Autoantibodies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lithiasis; Lung Diseases, Interstitial; Pulmonary Alveolar Proteinosis; Pulmonary Alveoli; Sirolimus	2006